Related Experiment Video
Updated: May 8, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple
1Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Summary
This review explores gene expression changes in the multiple sclerosis (MS) cortex. Understanding these genetic alterations in brain tissue may offer new insights into MS pathogenesis and disease progression.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system with unknown causes.
- The disease course is variable, often progressing from reversible episodes to irreversible disability due to continuous axonal and neuronal loss.
- Recent research highlights the significance of gray matter and cortical pathology in MS pathogenesis, with gene expression studies in the MS cortex still developing.
Purpose of the Study:
- To review and summarize existing data on gene expression changes in cortical tissues from individuals with MS.
- To explore how these gene expression alterations in the MS cortex may provide insights into the disease's underlying pathogenesis.
Main Methods:
- The review synthesizes findings from microarray-based comparative gene expression profiling studies.
- Data were analyzed from brain tissues of patients diagnosed with progressive forms of MS.
Main Results:
- Gene expression profiling offers a snapshot of genes involved in the condition.
- Emerging studies on MS cortical tissues are beginning to reveal key genetic factors.
Conclusions:
- Gene expression studies in the MS cortex are crucial for understanding disease mechanisms.
- Analyzing these genetic changes can illuminate pathways involved in MS pathogenesis and progression.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
